In addition, there is a growing interest in characterizing individuals based on AD-related pathology involving amyloid, tau and neurodegeneration (i.e., the A/T/N classification system) (40) that are also likely to have a polygenic basis. The gene discussed is MAPT; the disease is Alzheimer disease.